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Abstract. Complex regional pain syndrome (CRPS) is a chronic pain syndrome that causes intractable pain,
disability, and poor quality of life for patients. The etiology and pathophysiology of CRPS are still poorly under-
stood. Due to a lack of proper diagnostic tools, the prognosis of CRPS is primarily based on clinical observation.
The objective of this work is to evaluate a new imaging modality, photoacoustic microscopy (PAM), for assisting
diagnoses and monitoring the progress and treatment outcome of CRPS. Blood vasculature and oxygen sat-
uration (sO2) were imaged by PAM from eight adult patients with CRPS-1. Patients’ hands and cuticles were
imaged both before and after stellate ganglion block (SGB) for comparison. For all patients, both vascular struc-
ture and sO2 could be assessed by PAM. In addition, more vessels and stronger signals were observed after
SGB. The results show that PAM can help diagnose and monitor CRPS. © 2014 Society of Photo-Optical Instrumentation
Engineers (SPIE) [DOI: 10.1117/1.JBO.19.8.086017]
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1 Introduction
Complex regional pain syndrome (CRPS) is a pain disorder
characterized by severe and disproportionate pain, autonomic
changes such as abnormal regulation of blood flow and sweat-
ing, edema of skin and subcutaneous tissues, motor disorders,
and dystrophic changes. The pathophysiological mechanism of
CRPS is still poorly understood, although our knowledge of
this syndrome has increased significantly.1–3 Multiple factors,
including vascular and microcirculatory dysfunction, neurogenic
inflammation,4 and alteration in sympathetic and catecholami-
nergic function, as well as peripheral and central sensitization
may all play important roles in the pathogenesis of this disabling
syndrome.5 However, due to the connection between the micro-
vascular blood supply and the development of neuropathic
pain,6 microcirculatory parameters including rate and volume
of blood flow and tissue oxygen saturation (sO2) are of consid-
erable interest for potentially diagnosing CRPS and monitoring
its progress.
There is increasing evidence to show that inflammatory proc-
esses and immune reactions are involved in the pathophysiology
of CRPS.7 In a systemic review and meta-analysis study,
Parkitny et al.4 concluded that CRPS is associated with proin-
flammatory states in the blood, blister fluids, and cerebrospinal
fluid. The CRPS-related inflammation may change the sympa-
thetic tone of blood vessels and, therefore, affect blood supply
and tissue oxygenation. The acute and chronic phases of CRPS
demonstrate different inflammatory features in both clinical
manifestations and inflammatory profiles. The measurement of
microcirculatory parameters, such as blood flow rate, blood
volume, and blood oxygen saturation (sO2), can be used to
potentially diagnose the presence of CRPS, to indicate the activ-
ity of the disease, and to monitor the effectiveness of the thera-
peutic intervention.
In pain studies, traditional techniques for detecting microcir-
culatory parameters include functional magnetic resonance
imaging (fMRI) and positron emission tomography (PET).8
However, both have limitations: fMRI makes indirect measure-
ments by the blood-oxygenation-level dependent method9,10 or
makes direct flow measurements with low sensitivity by the
arterial spin labeling method;11 PET has to use radioactive trac-
ers to measure blood flow directly.12 To overcome these limita-
tions, optical methods provide alternative ways to make direct,
sensitive, noninvasive, and nonionizing measurements of blood
flow and sO2 in pain studies.
13–16 Optical spectroscopic meth-
ods, such as near-infrared spectroscopy13 and micro-lightguide
spectrophotometry,14 can provide noninvasive measurement of
average blood flow and sO2, but with poor spatial resolution.
Optical coherence tomography and optical Doppler imaging15,16
provide blood vasculature anatomy imaging with high spatial
resolution and sensitive measurements of flow speed, but lack
high sensitivity for measuring sO2 because their imaging con-
trasts are based on optical scattering.
Recently, photoacoustic microscopy (PAM) has emerged as a
powerful modality for biomedical imaging.17–19 In PAM, tissue
is irradiated by a short-pulsed laser beam. Some of the light is
absorbed and partially converted to heat, which subsequently
induces acoustic waves [termed photoacoustic (PA) waves]
via thermoelastic expansion. Because hemoglobin has strong
*Address all correspondence to: Xiaobin Yi and Lihong V. Wang, E-mail:
yix@anest.wustl.edu and lhwang@seas.wustl.edu 0091-3286/2014/$25.00 © 2014 SPIE
Journal of Biomedical Optics 086017-1 August 2014 • Vol. 19(8)
Journal of Biomedical Optics 19(8), 086017 (August 2014)
Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 06/17/2016 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
absorption in the visible spectral region, PAM has high sensi-
tivity in blood vasculature anatomy imaging20 and flow imag-
ing.21,22 In addition, because oxygenated hemoglobin (HbO2)
and deoxygenated hemoglobin (Hb) have different absorption
spectra, PAM can also accurately measure sO2. Thus, all the
aforementioned microcirculatory parameters, including blood
flow rate, blood volume, and blood oxygen saturation (sO2),
can be measured by PAM. So far, functional PAM has been suc-
cessfully demonstrated in both animals23–25 and humans.26
The diagnosis of CRPS is based on clinical manifestations
and there are limited laboratory tests or image studies to verify
the diagnosis. With its high spatial resolution and label-free
nature, PAM is potentially an ideal tool for monitoring and diag-
nosing CRPS by imaging peripheral blood perfusion. In this
work, we performed a series of experiments to show the feasibil-
ity of this new imaging tool.
2 Methods
2.1 Subjects
In this prospective observational study, we screened patients
with a possible diagnosis of CRPS-1, who were referred to
the Pain Management Center of Washington University in St.
Louis between January 2011 and December 2011. Nine adult
patients (28 to 69 years old, six female, three male) with
CRPS-1 were recruited. Patients with pain in only one upper
extremity were selected to participate in the study. One patient
withdrew from the study. Patients were considered to be candi-
dates for the study if they were diagnosed with CRPS-1 by
using the proposed new diagnostic criteria of the International
Association for the Study of Pain.27 All patients signed consents
to be involved in the study. All human research procedures
were carried out in conformity with the protocol approved by
the Institutional Review Board at Washington University in
St. Louis.
For all the patients, symptoms and signs of CRPS were
present for less than one year. Average pain level was 5 or higher
on a numerical rating score scale of 0 to 10 (with 0 being no pain
and 10 being the worst imaginable pain). Exclusion criteria
were pregnancy, coagulopathy, fever, general infection or
local infection at the block puncture site, substance abuse,
peripheral neuropathy, or any other diseases that may account
for signs and symptoms mimicking CRPS.
2.2 Procedures
Benefits and risks of stellate ganglion block (SGB) were
explained to the patients in detail. A written consent was
obtained for the procedure. ASA standard monitors were
applied during the procedure and postprocedure in the recovery
room. The skin temperature of the hands was measured before
and 10 min after the procedure. SGB on the cervical sympathetic
chain was performed at the C7 vertebral level using the standard
anterior paratracheal approach under fluoroscopic guidance.
The patient was placed in the supine position with the head
slightly hyperextended. The needle entry point was fluroscopi-
cally identified by anterior-posterior view at the junction of the
C7 vertebral body and transverse process on the side of the dis-
eased limb. Sterile techniques were used throughout the entire
procedure. After sterilization and preparation, 1 to 3 ml of 1%
lidocaine was used for skin infiltration at the needle entry point.
Then a 10-mm, 25-gauge nerve block needle was inserted and
advanced to the junction of the transverse process and the cor-
responding C7 vertebral body. Bony contact was made. The
appropriate needle positioning was confirmed by anterior-pos-
terior and lateral views. Once the needle was confirmed in the
correct position fluoroscopically, aspiration was made for neg-
ative blood and other body fluids. Then a small amount (0.5 to
1 ml) of contrast dye was injected to visualize and prevent
potential intravascular injection. After an adequate craniocaudal
contrast dye spread from C5 to T1 was obtained, an injection of
10 ml of 0.25% bupivacaine with 1:200,000 epinephrine was
given in 2-ml increments, with interval negative aspiration.
The patient was observed in the recovery area for 15 min
after the procedure. Skin temperature in the block side increased
1.1 0.1°C 10 min after SGB. Meanwhile, the pain level
reduced by 2.5 0.6 on discharge.
The experimental paradigm consisted of two imaging ses-
sions with an SGB between the sessions. For each patient,
the back of their hand and the cuticle of the same hand were
imaged before SGB (baseline) and then after SGB. Two sites
[Fig. 1(B)] were chosen to image: superficial microvasculature
at the cuticle and deeper and larger vessels at the back of
the hand.
2.3 Photoacoustic Microscopy
According to its light illumination mechanism, PAM can be
classified into two categories: acoustic-resolution (AR-) PAM
and optical-resolution (OR-) PAM. In AR-PAM, the light is
weakly focused and the lateral resolution is determined by
the acoustic focusing of the ultrasonic transducer. In OR-
PAM, the light is tightly focused, thus the lateral resolution
is determined by the optical focusing provided by the objective.
The axial resolution of both AR- and OR-PAM is determined by
the bandwidth of the transducer used in the system. Usually
optical focusing is much tighter than acoustic focusing, there-
fore, OR-PAM has a better lateral resolution than AR-PAM.
However, since acoustic scattering is much weaker than optical
scattering in soft tissue, AR-PAM can focus deeper than OR-
PAM. To monitor hemodynamic changes with both high spatial
resolution and deep penetration, both AR- and OR-PAM sys-
tems were used in this research. The schematics are shown in
Fig. 1(A). In the AR-PAM system, a donut-shaped illumination
is formed when light passes through the conical lens. A 20-MHz
ultrasonic transducer collects the PA signals. In the OR-PAM
system, light illumination and acoustic collection are achieved
by an ultrasound-optical beam combiner. A 50-MHz ultrasonic
transducer detects the PA signals. Each laser pulse generates a
one-dimensional depth-resolved image (A-line) in both the AR-
and OR-PAM systems. By two-dimensional (2-D) raster-scan-
ning of the entire area, a three-dimensional (3-D) image can be
acquired. For more accurate sO2 calculation in both AR- and
OR-PAM systems, a photodiode compensates for the local flu-
ence fluctuation. A detailed system description can be found in
our previous papers.28–30 The lateral resolutions of the AR- and
OR-PAM systems are 80 and 3 μm, respectively. To measure
sO2, light at two wavelengths, 570 and 578 nm, was used in
both AR- and OR-PAM. The PA signal from both wavelengths
can be described as
Pðλ1Þ ¼ k × ½εHbðλ1ÞCHb þ εHbO2ðλ1ÞCHbO2 ; (1)
Pðλ2Þ ¼ k × ½εHbðλ2ÞCHb þ εHbO2ðλ2ÞCHbO2 ; (2)
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where P denotes PA signal amplitude, λ1 and λ2 denote the first
and second wavelengths, k denotes a system-dependent con-
stant, ε denotes the molar extinction coefficient, Hb denotes
deoxygenated hemoglobin, HbO2 denotes the oxygenated
hemoglobin, and C denotes the molar concentration. Based on
Eqs. (1) and (2), we can solve forCHb andCHbO2. In the end, sO2






Typical AR- and OR-PAM hand images of patients are shown in
Figs. 2 and 3, respectively. For fair comparisons, the distance
Fig. 1 (A) Schematic of the optical-resolution (OR-PAM) and acoustic-resolution photoacoustic micros-
copy (AR-PAM) systems. AL, acoustic lens; CL, conical lens; DAQ, data acquisition system; M, mirror;
UT, ultrasound transducer. (B) Photograph of the hand, showing the scanned regions: (a) region scanned
by AR-PAM and (b) region scanned by OR-PAM.
Fig. 2 Maximum amplitude projection (MAP) images of vasculature in the back of one patient’s hand by
AR-PAM. MAP image in the depth range between 0.4 and 0.7 mm before block (a) and after block (b).
MAP image in the depth range between 0.7 and 1 mm before block (c) and after block (d). NPA,
normalized photoacoustic amplitude.
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between the patient’s hand and the ultrasonic transducer was
adjusted to be the same before and after SGB for imaging. In
AR-PAM, a ∼6 mm by 6 mm field of view was scanned.
Signals down to 1 mm deep were collected. Due to the high
axial resolution of AR-PAM, we were able to differentiate sig-
nals from different depths. Maximum-amplitude-projection
images along the depth direction, with ranges of 0.4 to
0.7 mm and 0.7 to 1.0 mm, are shown in Fig. 2. Two major
differences can be easily seen: more blood vessels and stronger
signals after the block. Because the local optical fluence fluc-
tuation had been compensated for, the PA signal was mainly
dependent on the absorption coefficient of the target. Thus,
an increase in the PA signal indicates an increase in the local
absorption coefficient, probably due to increased blood concen-
tration or volume. Therefore, we suspect that there was increas-
ing blood perfusion and blood vessel dilation after the block.
Typical blood vessels in the finger cuticle imaged by
OR-PAM are shown in Fig. 3. As indicated in Figs. 3(b) and
3(c), OR-PAM successfully imaged a single capillary loop,
which is the smallest vessel in human blood circulation.31 As
shown in Fig. 3(b), a stronger signal was found after the
block which is consistent with the results from AR-PAM.
Statistical analysis of all the patient data are shown in Fig. 4.
Figure 4(a) shows the average increase in signal intensity at
different depths after the block. On average, there was >50%
signal increase in all depth ranges. In addition, the signal
increased most within the 0.1- to 0.4-mm depth range, where
the capillary bed is located. Similar results from OR-PAM can
be found in Fig. 4(c). According to the dual-wavelength meas-
urement by AR-PAM, the average sO2 increased ∼4%.
4 Discussion
CRPS-1 is a difficult clinical condition to diagnose and treat.
Early diagnosis and management are necessary to prevent a long-
standing or permanent disability. The diagnosis of CRPS-1
is primarily based on clinical observation and assessment of
Fig. 3 OR-PAM vasculature image of the fingertip of one patient. MAP of scanned region before block (a)
and after block (b). The dashed box represents the region used for statistical analysis. (c) Close-up image
of the capillary loop indicated by the arrow in (b).
Fig. 4 (a) Normalized photoacoustic (PA) signal measured by AR-PAM before and after block in different
depth ranges. (b) Average sO2 measured by AR-PAM before and after block. (c) Normalized PA signal
measured by OR-PAM before and after block.
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symptoms and signs, although a diagnostic algorithm has
recently been proposed.32 A unique pathophysiological mecha-
nism for CRPS-1 has not yet been established, therefore, sensi-
tive and specific laboratory diagnostic parameters are lacking,
resulting in difficulties in making valid diagnosis and distin-
guishing CRPS from other extremity pain entities. Several
diagnostic procedures, such as bone scintigraphy, plain radio-
graphs, quantitative sensory testing, skin temperature measure-
ments, and fMRI are used to support the diagnosis of CRPS.
However, they require pathognomonic markers. For example,
the recommended three-phase bone scan demonstrated both
cortical and cancellous osteopenia in CRPS patients and con-
trols treated with casting.33 Meanwhile, there are no universally
accepted tools to measure the effectiveness of treatment. It is
known that CRPS is accompanied by impaired microcirculation
of the affected tissue,34–36 such as vasoconstriction and reduced
regional blood flow37 and oxygenation,14 which then leads to
skin temperature change,34,38 pain, and atrophic changes.
Thus, a direct noninvasive measurement of microcirculation
is of considerable interest for accurate and early diagnosis of
CRPS. PAM is shown to be a powerful tool for studying the
microcirculatory system at the site of CRPS. In the presented
results, the blood perfusion increase after SGB was directly
observed, which is consistent with the patients’ subjective
sense of pain relief. Based on time-of-flight in the depth direc-
tion and raster 2-D scanning in the horizontal direction, PAM
can reconstruct 3-D information of the blood vessel anatomy
and the distributions of hemoglobin concentration and oxygen
saturation, which may provide additional information for diag-
nosis and improvement after treatment. Our experiments show
that a relatively obvious blood perfusion increase after SGB
exists at the shallow depth where the capillary bed is located.
Although the data are preliminary, they suggest a strong relation
between the development of CRPS and microcirculatory
changes.
PAM is able to measure the oxygen saturation in a single
blood vessel29 or the average values in a desired area. Pain, auto-
nomic changes, and functioning impairment in patients with
CRPS may be related more to the actual tissue extraction of
oxygen and nutrients in the affected area than to the supply of
oxygen and nutrients from microcirculation. Some reports sug-
gest that arterial oxygen saturation alone may not be helpful
enough to diagnose CRPS,39,40 thus venous oxygen saturation
is essential.40 Due to its absorption contrast mechanism,
PAM with double wavelengths is sensitive to both oxyhemoglo-
bin and deoxyhemoglobin, and is able to measure the oxygen
saturation in both arteries and veins.
SGB with local anesthetics is used frequently in the manage-
ment of CRPS-1 of the upper extremities, with variable degrees
of success in pain relief and improvement of function.5 This
inconsistency of outcome may be related to sympathetically
maintained pain (SMP) and sympathetically independent pain
(SIP).41 SMP may be differentiated from SIP by a sympatholytic
challenge provided by an intravenous injection of the α-adrener-
gic blocker phentolamine or sympathetic blocks.42,43 Our pre-
liminary data indicated only a subset of patients responded to
SGB well, with significant pain relief and changes of PA signal
and sO2, which supports the observation that “neuropathic pain
is mediated or maintained by the sympathetic nervous system in
only a subset of patients.”43
Despite the advantages listed above, the 2-D scanning of cur-
rent PAM has a relatively long acquisition time, which leads to
some motion artifacts in the image. Further improvement of im-
aging speed is possible by implementing mirror scanning.44
Limited by the strong attenuation of high-frequency acoustic
signals, the AR-PAM system used in this work can image only
as deep as 3 mm in biological tissue. To investigate the micro-
circulatory changes of deep tissue, such as muscles and bones in
the area affected by CRPS, an AR-PAM system with a lower
central frequency transducer (e.g., 5 MHz) can be used in
the future, which would extend the imaging depth to 4 cm.25
Based on a small number of subjects, our data are promising
but preliminary. Randomized, controlled, and double-blinded
clinical trials are needed to verify the clinical application of
PAM systems to CRPS evaluation and management.
5 Conclusion
In this paper, peripheral blood vessels in two sites in patients’
hands were imaged by PAM systems. From pre- to post-SGB
block, there were a 50% increase in signal intensity of PAM
and 4% increase in sO2, which agreed with the increased tem-
perature and decreased pain level.6,7 The results showed that
blood perfusion increased after SBG, which is consistent
with prior reports. Unlike other imaging methods, PAM can
provide noninvasive high spatial resolution images as well as
functional sO2 measurement. In these preliminary results, PAM
showed its potential in helping both monitoring and diagnos-
ing CRPS.
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